Windlas Biotech has concluded its European Union GMP Inspection carried out by National Institute of Pharmacy and Nutrition, Hungary for the Plant-IV situated at Dehradun with zero critical observations. The company had undergone this inspection from April 11 to 13, 2022.
Windlas Biotech is into domestic pharmaceutical formulations contract development and manufacturing business.